Sarissa Capital Management LP Cytokinetics Inc Transaction History
Sarissa Capital Management LP
- $323 Million
- Q4 2024
A detailed history of Sarissa Capital Management LP transactions in Cytokinetics Inc stock. As of the latest transaction made, Sarissa Capital Management LP holds 833,799 shares of CYTK stock, worth $36.2 Million. This represents 12.15% of its overall portfolio holdings.
Number of Shares
833,799
Previous 1,110,000
24.88%
Holding current value
$36.2 Million
Previous $58.6 Million
33.08%
% of portfolio
12.15%
Previous 14.58%
Shares
3 transactions
Others Institutions Holding CYTK
# of Institutions
397Shares Held
122MCall Options Held
3.46MPut Options Held
1.86M-
Black Rock Inc. New York, NY14.7MShares$637 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.9MShares$518 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD10.8MShares$467 Million0.31% of portfolio
-
Wellington Management Group LLP Boston, MA7.89MShares$343 Million0.07% of portfolio
-
State Street Corp Boston, MA6.17MShares$268 Million0.01% of portfolio
About CYTOKINETICS INC
- Ticker CYTK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,144,096
- Market Cap $4.09B
- Description
- Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...